Next Article in Journal
Magnolol, a Natural Polyphenol, Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice
Next Article in Special Issue
New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
Previous Article in Journal
The Hydrogen Sulfide-Vitamin B12-Folic Acid Axis: An Intriguing Issue in Chronic Kidney Disease. A Comment on Toohey JI: “Possible Involvement of Hydrosulfide in B12-Dependent Methyl Group Transfer”. Molecules 2017, 22, 582, pii: E582
Previous Article in Special Issue
NMR Insights into the Structure-Function Relationships in the Binding of Melanocortin Analogues to the MC1R Receptor

Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics

Department of Pharmacy, University of Naples Federico II, via Mezzocannone 16, 80134 Naples, Italy
Dipartimento di Scienze e Tecnologie Ambientali Biologiche Farmaceutiche, University of Campania “Luigi Vanvitelli”, Via G. Vivaldi 42, 81100 Caserta, Italy
CEINGE-Biotecnologie Avanzate Scarl, Via G. Salvatore 486, 80145 Napoli, Italy
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli “Federico II”, 80131 Napoli, Italy
Authors to whom correspondence should be addressed.
These two authors contributed equally.
Molecules 2017, 22(7), 1217;
Received: 28 June 2017 / Revised: 17 July 2017 / Accepted: 18 July 2017 / Published: 20 July 2017
(This article belongs to the Special Issue Peptide-Based Drugs and Drug Delivery Systems)
Cyclic peptides are receiving significant attention thanks to their antimicrobial activity and high serum stability, which is useful to develop and design novel antimicrobial agents. Antimicrobial peptides appear to be key components of innate defences against bacteria, viruses, and fungi. Among the others, defensins possess a strong microbicidial activity. Defensins are cationic and amphipathic peptides with six cysteine residues connected by three disulfide bonds found in plants, insects, and mammals; they are divided in three families: α-, β-, and θ-defensins. α-Defensins are contained in the primary granules of human neutrophils; β-defensins are expressed in human epithelia; and θ-defensins are pseudo-cyclic defensins not found in humans, but in rhesus macaques. The structural diversities among the three families are reflected in a different antimicrobial action as well as in serum stability. The engineering of these peptides is an exciting opportunity to obtain more functional antimicrobial molecules highlighting their potential as therapeutic agents. The present review reports the most recent advances in the field of cyclic peptides with a specific regard to defensin analogs. View Full-Text
Keywords: defensins; defensin analogs; antimicrobial drugs; cyclic peptides defensins; defensin analogs; antimicrobial drugs; cyclic peptides
Show Figures

Graphical abstract

MDPI and ACS Style

Falanga, A.; Nigro, E.; De Biasi, M.G.; Daniele, A.; Morelli, G.; Galdiero, S.; Scudiero, O. Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics. Molecules 2017, 22, 1217.

AMA Style

Falanga A, Nigro E, De Biasi MG, Daniele A, Morelli G, Galdiero S, Scudiero O. Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics. Molecules. 2017; 22(7):1217.

Chicago/Turabian Style

Falanga, Annarita; Nigro, Ersilia; De Biasi, Margherita G.; Daniele, Aurora; Morelli, Giancarlo; Galdiero, Stefania; Scudiero, Olga. 2017. "Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics" Molecules 22, no. 7: 1217.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop